针对TDO2作为肺腺癌治疗的潜在目标
Er Jin1, Zhidong Yin2, Xiuxiu Zheng1
1Department of Respiratory Medicine, Affiliated Hangzhou First People's Hospital, Zhejiang University School of Medicine, Hangzhou 310002 Zhejiang Province, China.
Journal of proteome research
|February 29, 2024
概括
托芬代谢是肺腺癌 (LUAD) 的关键. 准TDO2,这条途径中的酶,可能通过影响癌细胞增殖和免疫抑制,为LUAD瘤提供一种新的治疗策略.
科学领域:
- 生物化学 生物化学
- 在瘤学瘤学.
- 免疫学 免疫学 免疫学
背景情况:
- 托芬催化作用对癌细胞代谢至关重要,支持瘤生长和进展.
- 丁氨酸是一种托芬代谢物,可以抑制抗瘤免疫反应.
- 二二氧化酶 (TDO) 在肺腺癌 (LUAD) 中的作用需要进一步研究.
研究的目的:
- 调查TDO在LUAD中的重要性.
- 探索TDO2表达和LUAD细胞行为之间的关联.
- 评估TDO2作为LUAD的潜在治疗点.
主要方法:
- 进行了内部和外部队列研究.
- 分析了与LUAD特征相关的TDO2表达水平.
- 评估了针对TDO2对LUAD细胞的影响.
主要成果:
- 在LUAD中,TDO2表达很重要.
- TDO2表达与LUAD细胞的增殖,生存和入侵有关.
- 准TDO2显示出作为LUAD治疗策略的潜力.
结论:
- 二二氧化酶 (TDO2) 在肺腺癌中起着重要作用.
- TDO2表达影响LUAD进展的关键方面,包括扩散,生存和入侵.
- 抑制TDO2为治疗LUAD提供了一个有前途的治疗途径.
更多相关视频
06:03Orthotopic Transplantation of Syngeneic Lung Adenocarcinoma Cells to Study PD-L1 Expression
Published on: January 19, 2019
17.0K
06:51Utilizing 18F-FDG PET/CT Imaging and Quantitative Histology to Measure Dynamic Changes in the Glucose Metabolism in Mouse Models of Lung Cancer
Published on: July 21, 2018
17.9K
相关概念视频
Targeted Cancer Therapies
7.6K
The targeted cancer therapies, also known as “molecular targeted therapies,” take advantage of the molecular and genetic differences between the cancer cells and the normal cells. It needs a thorough understanding of the cancer cells to develop drugs that can target specific molecular aspects that drive the growth, progression, and spread of cancer cells without affecting the growth and survival of other normal cells in the body.
There are several types of targeted therapies against...
There are several types of targeted therapies against...
7.6K
Tumor Immunotherapy
524
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
524
